Transfection efficiency—the proportion of cells successfully taking up and expressing foreign genetic material—is a critical parameter in lung cancer functional genomics studies. High transfection efficiency ensures that a sufficient number of cells express the gene of interest or silenced target, enabling reliable downstream analysis such as gene function, signaling pathways, and drug response mechanisms. Lung…
Lipid nanoparticles (LNPs) have emerged as a transformative platform for delivering RNA molecules, such as mRNA and siRNA, into lung tumor cells. These nanoscale carriers protect RNA from enzymatic degradation, facilitate cellular uptake, and enable efficient release of their cargo into the cytoplasm, overcoming major barriers in gene therapy and molecular research. The unique physiological…
Transfecting non-adherent lung cancer cells presents unique technical challenges due to their growth characteristics and membrane properties. Unlike adherent cells that grow attached to surfaces, many lung cancer cell lines—especially those derived from small cell lung carcinoma or circulating tumor cells—grow in suspension, making traditional transfection methods less effective. Non-adherent cells often exhibit reduced uptake…
CRISPR/Cas9 genome editing technology has revolutionized functional genomics and therapeutic development by enabling precise, efficient, and versatile modification of DNA sequences. In lung adenocarcinoma research, CRISPR/Cas9 facilitates the study of gene function, identification of cancer drivers, and development of targeted therapies. However, delivering CRISPR components effectively into lung adenocarcinoma cell lines such as A549, HCC827,…
Electroporation remains one of the most effective physical methods for introducing nucleic acids such as DNA, RNA, and CRISPR components into lung cancer cells, especially those that are difficult to transfect using chemical reagents. This technique uses short, high-voltage electrical pulses to transiently permeabilize the cell membrane, allowing charged molecules to enter the cytoplasm. Over…
The process of gene expression following RNA transfection typically involves several key steps. Here’s an overview of how this process works, focusing on mRNA transfection as an example: 1. Transfection The first step is the actual process of transfection, where the RNA molecules are introduced into the cells. This can be done using a variety…
RNA modifications can greatly influence the stability, immunogenicity, and translation efficiency of RNA, and therefore, can have a significant impact on transfection efficiency. Here are a few key RNA modifications and how they affect transfection: 1. 5′ Cap Modification Most eukaryotic mRNAs possess a “cap” structure at their 5′ end. This cap is critical for…
Delivery of RNA into specific tissues or organs is a significant challenge in the field of RNA therapeutics. However, several strategies have been developed to address this issue, each with its own advantages and potential limitations. Each of these strategies has its own advantages and potential limitations, and the choice of method will depend on…
Non-viral methods for RNA transfection offer alternative approaches to deliver RNA into cells without the use of viral vectors. Here are two commonly used non-viral methods for RNA transfection: Both electroporation and microinjection have their own advantages and limitations: It’s important to note that while these non-viral methods provide efficient delivery of RNA, they may…
Optimizing RNA delivery parameters is crucial for achieving efficient and effective transfection. Here are some key parameters that can be optimized for RNA delivery: 1. RNA Concentration: The concentration of RNA used for transfection can significantly impact transfection efficiency. It is important to find the optimal concentration that provides sufficient RNA molecules for effective delivery…
